This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: coronary disease

Rivaroxaban in non-valvular AF – UK experience in perspective

September 2014 Br J Cardiol 2014;21(suppl 1):S1–S11

Rivaroxaban in non-valvular AF – UK experience in perspective

Diana A Gorog

Abstract

ESC guidelines and differences between NOACs Following the roll-out of the novel oral anticoagulants (NOACs), the European Society of Cardiology (ESC) published in 2012 a focused update of its guidelines for the management of atrial fibrillation (AF). Since the NOACs tested in clinical trials all showed at least non-inferiority when compared with vitamin K antagonists (VKAs), with a better safety profile, particularly with reduction in intracranial haemorrhage (ICH), the ESC 2012 guideline recommended NOACs as broadly preferable to VKAs in the vast majority of patients with non-valvular AF (NVAF).1 In 2013, the European Heart Rhythm Associati

| Full text

September 2007 Br J Cardiol 2007;14:215-218

One-year data from the UK arm of the REACH Registry

Jonathan M Morrell, George C Kassianos

Abstract

As with the global results, there was a high use of evidence-based therapies in the UK patients. Despite this, the combined incidence of cardiovascular events at one year (cardiovascular death, myocardial infarction, stroke) was high at 4.82%, 4.46% and 4.35% respectively for peripheral arterial disease (PAD), cerebrovascular disease (CVD) and coronary artery disease (CAD). These figures increase markedly when hospitalisations are taken into account, particularly in patients with PAD (18.54%) compared with CVD (8.29%) and CAD (10.07%). Cardiovascular event rates increased significantly with the number of symptomatic locations (p=0.0043), incr

| Full text

May 2007 Br J Cardiol 2007;14:153-59

Baseline data from the UK arm of the REACH Registry

Jonathan M Morrell, George C Kassianos For The Reach Registry Investigators

Abstract

No content available

| Full text

March 2007 Br J Cardiol 2007;14:90-7

Stress echocardiography – current status

Roxy Senior, John Chambers

Abstract

No content available

| Full text

January 2005 Br J Cardiol 2005;12:50-2

Audit of cardiac rehabilitation in light of the National Service Framework for coronary heart disease

Fiona Taylor, Andrew Beswick, Jackie Victory, Karen Rees, Ingolf Griebsch, Robert West, Rod Taylor, Jackie Brown, Margaret Burke, Shah Ebrahim

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now